Froment’s sign is an unusual neurological phenomenon that has been puzzling medical professionals for centuries. It is characterized by a sudden decrease in muscle strength in the thumb and index finger when attempting to pinch an object between them. This phenomenon is often associated with a diagnosis of ulnar nerve palsy, a condition caused by damage to the ulnar nerve at the elbow. Despite its long history, the exact cause of Froment’s sign remains a mystery. In this article, we will take a closer look at this unusual neurological phenomenon and explore the various theories that have been proposed to explain it.
Froment’s sign was first described in the late 19th century by French physician Alfred Froment. He observed that some of his patients experienced a sudden decrease in muscle strength in the thumb and index finger when attempting to pinch an object between them. In the decades since, the phenomenon has been observed in patients with a variety of neurological conditions, including ulnar nerve palsy, brachial plexus injuries, and multiple sclerosis.
The exact cause of Froment’s sign remains a mystery. However, several theories have been proposed to explain the phenomenon. One of the most popular theories is that the sign is caused by damage to the ulnar nerve at the elbow. The ulnar nerve is responsible for providing sensation to the thumb and index finger, and damage to this nerve can cause a decrease in muscle strength in these fingers. Another theory suggests that the sign is caused by damage to the brachial plexus, a network of nerves that runs from the neck to the arm. Damage to these nerves can cause a decrease in muscle strength in the thumb and index finger, leading to Froment’s sign. Finally, some researchers believe that the sign is caused by damage to the central nervous system. This damage can affect the ability of the brain to send signals to the muscles in the thumb and index finger, resulting in a decrease in muscle strength.
Froment’s sign is typically diagnosed through a physical examination. During the examination, the doctor will ask the patient to pinch an object between their thumb and index finger. If the patient experiences a sudden decrease in muscle strength in these fingers, the doctor may diagnose Froment’s sign. In addition to the physical examination, the doctor may order additional tests to confirm the diagnosis. These tests may include an electromyography (EMG) to measure the electrical activity of the muscles in the thumb and index finger, or an imaging scan to check for damage to the ulnar nerve or brachial plexus.
The treatment for Froment’s sign depends on the underlying cause. If the sign is caused by damage to the ulnar nerve or brachial plexus, the doctor may recommend physical therapy to help strengthen the muscles in the thumb and index finger. In some cases, surgery may be necessary to repair the damaged nerves. If the sign is caused by damage to the central nervous system, the doctor may recommend medications to help improve muscle strength. In some cases, the doctor may also recommend lifestyle changes, such as quitting smoking or participating in regular exercise, to help improve muscle strength.
Froment’s sign is an unusual neurological phenomenon that has been puzzling medical professionals for centuries. Although the exact cause of the sign remains a mystery, several theories have been proposed to explain it. The diagnosis of Froment’s sign is typically made through a physical examination and may be confirmed with additional tests. The treatment for the sign depends on the underlying cause and may include physical therapy, surgery, medications, and lifestyle changes.
1.
Inner Thoughts of Leonard Bernstein, the "Maestro".
2.
Mobile prostate cancer screening clinic can ID the disease in disadvantaged men
3.
No Survival Benefit Seen With Adjuvant Atezolizumab in TNBC
4.
Parents, teachers at Missouri school want answers after string of cancer diagnoses
5.
A promising medication could slow brain tumors in children.
1.
Future-Ready Cancer Screening: What Every Clinician Should Know in 2025
2.
Cancer Evolution and Therapeutic Resistance: Mechanisms, Clinical Insights, and Emerging Strategies
3.
Targeting Cancer Stem Cells in Solid Tumors: Mechanisms, Clinical Implications, and Therapeutic Advances
4.
Partial Gland Ablation in Prostate Cancer: Oncologic Outcomes in Intermediate-Risk Cases
5.
Generative AI for Adaptive Oncology Trial Design
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
5.
Current Scenario of Cancer- The Incidence of Cancer in Men
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation